News

ASCEND trial to test HCV treatment in primary care setting


 

References

The new ASCEND trial will examine whether primary care physicians can use a new antiviral therapy to treat hepatitis C virus as effectively as specialists do, according to a press release from the National Institutes of Health.

While past treatments for HCV were long-term, complex, and generally required a specialist physician, new drug developments may not require such in-depth treatment and could be handled by a primary care physician. The ASCEND study will involve 600 patients in the Washington, D.C. area, with 350 patients continuing their normal treatment with a specialist, and 250 patients receiving their treatment at a primary care location. Both groups will receive the same medication.

“The recent advent of direct-acting antiviral medications has offered promising new treatment options for people who are chronically infected with hepatitis C,” Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Disease, said. “The ASCEND study will help determine whether these medications are similarly effective when administered in an urban, community-based setting.”

Find the full press release on the NIH website.

Recommended Reading

Infliximab most common cause of drug-induced liver injury
MDedge Family Medicine
Stress independently predicts peptic ulcers
MDedge Family Medicine
Difficult-to-clean ERCP duodenoscopes linked to serious infections
MDedge Family Medicine
Two regimens achieve high response in HCV/HIV coinfection
MDedge Family Medicine
Death rates rising for liver cancer, falling for colorectal cancer
MDedge Family Medicine
C. difficile responsible for nearly a half million infections in the United States
MDedge Family Medicine
Emulsifiers alter gut bacteria in mice, set the stage for IBD and metabolic syndrome
MDedge Family Medicine
C. difficile burden in U.S. documented in 2011 estimates of infections, deaths
MDedge Family Medicine
What you must know before you recommend a probiotic
MDedge Family Medicine
Environmental factors could increase U.S. anthrax cases
MDedge Family Medicine